1. Home
  2. BWAY vs WEYS Comparison

BWAY vs WEYS Comparison

Compare BWAY & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • WEYS
  • Stock Information
  • Founded
  • BWAY 2003
  • WEYS 1906
  • Country
  • BWAY Israel
  • WEYS United States
  • Employees
  • BWAY N/A
  • WEYS N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • WEYS Apparel
  • Sector
  • BWAY Health Care
  • WEYS Consumer Staples
  • Exchange
  • BWAY Nasdaq
  • WEYS Nasdaq
  • Market Cap
  • BWAY 280.7M
  • WEYS 303.5M
  • IPO Year
  • BWAY 2019
  • WEYS N/A
  • Fundamental
  • Price
  • BWAY $15.20
  • WEYS $30.85
  • Analyst Decision
  • BWAY Strong Buy
  • WEYS
  • Analyst Count
  • BWAY 2
  • WEYS 0
  • Target Price
  • BWAY $18.00
  • WEYS N/A
  • AVG Volume (30 Days)
  • BWAY 70.6K
  • WEYS 16.0K
  • Earning Date
  • BWAY 08-13-2025
  • WEYS 08-05-2025
  • Dividend Yield
  • BWAY N/A
  • WEYS 3.73%
  • EPS Growth
  • BWAY 515.14
  • WEYS N/A
  • EPS
  • BWAY 0.11
  • WEYS 2.69
  • Revenue
  • BWAY $46,084,000.00
  • WEYS $281,051,000.00
  • Revenue This Year
  • BWAY $341.83
  • WEYS N/A
  • Revenue Next Year
  • BWAY $23.42
  • WEYS N/A
  • P/E Ratio
  • BWAY $52.60
  • WEYS $11.47
  • Revenue Growth
  • BWAY 26.50
  • WEYS N/A
  • 52 Week Low
  • BWAY $7.06
  • WEYS $25.51
  • 52 Week High
  • BWAY $15.61
  • WEYS $41.05
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 78.88
  • WEYS 52.68
  • Support Level
  • BWAY $14.33
  • WEYS $27.83
  • Resistance Level
  • BWAY $15.00
  • WEYS $30.29
  • Average True Range (ATR)
  • BWAY 0.56
  • WEYS 1.48
  • MACD
  • BWAY 0.33
  • WEYS 0.07
  • Stochastic Oscillator
  • BWAY 90.26
  • WEYS 70.56

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.

Share on Social Networks: